Hot Products

Eupalinilide B
Catalog No: CFN90378

Eupalinilides B demonstrates potent cytotoxicity against P-388 and A-549 tumor cell lines.

Eupalinilide C
Catalog No: CFN90379

Eupalinilide C is a natural product from Impatiens balsamina L.

Eupalinolide A
Catalog No: CFN90381

Eupalinolide A and Eupalinolide B induce the expression of HSP70 via the activation of HSF1 by inhibiting the interaction between HSF1 and HSP90. They could be beneficial for use in cosmetics and medicines as a consequence of their inhibitory action on UV-induced skin damage and melanin production.

Eupalinolide B
Catalog No: CFN90382

Eupalinolide B demonstrates potent cytotoxicity against A-549, BGC-823, SMMC-7721, and HL-60 tumour cell lines.Eupalinolide B and Eupalinolide A induce the expression of HSP70 via the activation of HSF1 by inhibiting the interaction between HSF1 and HSP90, they could be beneficial for use in cosmetics and medicines as a consequence of their inhibitory action on UV-induced skin damage and melanin production.

Eupalinolide K
Catalog No: CFN99435

Reference standards.

Eupalinolide O
Catalog No: CFN91839

Eupalinolide O shows significant anticancer activity, it induces cell cycle arrest and apoptosis in human MDA-MB-468 breast cancer cells.

Eupalitin
Catalog No: CFN70334

Eupalitin has anti-cancer activity, it induces apoptosis in prostate carcinoma cells through ROS generation and increase of caspase-3 activity.

Euparin
Catalog No: CFN96884

Euparin exhibits a moderate antioxidant activity, it also exhibits antifungal activity against Trichophyton mentagrophytes. Euparin has antiviral activity, it exerts its effect during the early events of the replication cycle, from the virus adsorption to cells up to the first twenty minutes after infection.

Eupatilin
Catalog No: CFN90190

Eupatilin has anti-inflammatory, and anti-tumor properties, it inhibits the MKN-1 gastric cancer cell proliferation via activation of caspase-3 and the metastatic potential of gastric cancer cells via down-regulation of NF-κB activity followed by reduction of pro-inflammatory cytokine-mediated MMPs expressions. Eupatilin inhibits the signalling of MAPK, IKK, NF-κB and eotaxin-1 in bronchial epithelial cells, leading to inhibition of eosinophil migration. Eupatilin is also a promising therapeutic agent against acute ischemia-induced renal damage, it significantly increases the levels of heat shock protein 70 and B-cell lymphoma protein, and it attenuates inducible nitric oxide synthase, Bcl-2-associated X protein, and caspase-3 levels.

Eupatoletin
Catalog No: CFN92698

Reference standards.